Ipca Lab Q4 net profit up 84% at Rs 137 cr

Drug firm Ipca Laboratories today posted 84.10% jump in net profit at Rs 137.03 crore for the fourth quarter ended March 31, 2013-14.

The company had reported net profit of Rs 74.43 crore during the January-March same period of the 2012-13 fiscal.

Net sales of the company during Q4, 2013-14 were Rs 739.81 crore, up 12.32% from Rs 658.64 crore in the year-ago period, Ipca Laboratories said in a filing to the BSE.

The company's Q4 revenue from domestic formulations business stood at Rs 196.56 crore, up 10%, while the revenue from exports stood at Rs 373.18 crore, up 19%.

The Ipca Labs scrip was trading at Rs 785 on the BSE in the afternoon trade, down 0.39% from the previous close.

EDITORIAL OF THE DAY

  • HDFC Bank has triggered market competition by lowering base rate

    Even nine months after the Reserve Bank of India (RBI) changed its monetary stance and started reducing key policy rates, both public and private sect

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Roopen Roy

Startups to bring change for good

It is a widely held belief that our new generation ...

Rajgopal Nidamboor

The quest for the greater self

All of us have our own outlook, or view, of ...

Dharmendra Khandal

Elephants are killed for those ivory bangles

Wildlife lovers always curse China for making products out of ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture